stocksbrew
Pulse
Daily
Social
Radar
Pulse
Daily
Social
Radar
stocksbrew.

Stock watchlist guidance and alerts for the US stocks you follow.

Live now

Product

  • Market Pulse
  • Social
  • Radar
  • Pre-market movers
  • Market Daily
  • Earnings
  • US stocks
  • Stock sectors
  • AI agent access

Free tools

  • All free tools
  • Should I Buy?
  • Compare stocks
  • Portfolio Analyzer
  • Position calculator
  • Market Heat
  • Screens

Resources

  • Learn & guides
  • Blog
  • Stock analysis apps
  • Fundamental analysis
  • Earnings template
  • Use cases
  • Compare stocksbrew
  • Developer API

Company

  • About
  • Editorial policy
  • Author
  • Pricing
  • Contact
  • Terms of service
  • Privacy policy
  • Cookie policy
  • Disclaimer
stocksbrew — Verified on SubmitForBacklinksFeatured on ScrollLaunchFeatured on DanielLaunchesLaunched on FazierStocksBrew - Featured on Startup FameFeatured on ToolPilot.aiFeatured on Wired BusinessFeatured on Twelve ToolsFeatured on Aura++Listed onAI Toolz DirFeatured on Dofollow.ToolsFeatured on Hi CyouVerified on directreeListed on Huzzler
Listed onAI Toolz Dir

© 2026 stocksbrew. All rights reserved.

stocksbrew provides market data and analytics for informational purposes only. Nothing here is investment advice. Past performance does not guarantee future results.

GK
GKOS stock logo

GKOS

Glaukos Corp.

$170.80

▲ +2.45%

+$4.08

NYSE · Healthcare · Medical Devices

· price updated 9h ago

GK
GKOS stock logo

Glaukos Corp.

GKOS · NYSE · Healthcare · Medical Devices · price updated 9h ago

$170.80

▲ +2.45% · +$4.08 today

DecisionEvidence

AI research · $170.80

Track GKOS for continuous AI research

price position

Where GKOS sits now

52-week range
Low$73.16
High$166.00
Today $170.80
RSI (14)
74.3Overbought
03070100
fundamentals

Business quality and valuation

overall score

49.4/100

Compared with sector peers · 79% coverage

key figures

P/E (TTM)n/a
EPS next Y+263.8%
Beta0.75
Market cap$9.83B

ttm snapshot

Revenue

$612.84M

Net income

$-188.05M

EPS

$-3.25

Op. income

$-193.36M

Gross profit

$484.88M

Rev growth

+41.5%

Operating record

What the business has actually produced

Revenue

Capital structure

Cash versus debt

Cash & investments$286.2M
Total debt$102.8M
Net cash after debt$183.4M

Valuation

What the market charges

Forward P/E

Price against expected earnings

Needs attention · 1724% above Sector avg

1608.20x

Price / sales

Value assigned to each sales dollar

Rich · Above 8x annual sales

16.04x

Price / FCF

Price against free cash generation

No signal · Not enough data to judge

-

EV / EBITDA

Operating value including debt

No signal · Not enough data to judge

-

Quality

How efficiently it compounds

ROIC

Return earned on invested capital

Weak · Below 8% return on capital

-15.7%

ROE

Profit generated from shareholder equity

Needs attention · Among weakest in sector

-26.0%

Debt / equity

Balance-sheet leverage

Favorable · Exceptional vs sector peers

0.16x

Current ratio

Short-term assets against liabilities

Strong · Comfortable short-term liquidity

5.04x

Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.

peer comparison

How GKOS compares

companymkt capP/Erev growthscore
GK
GKOS stock logo
GKOSGlaukos Corp.
$9.83B-+41.5%49
GM
GMED stock logo
GMEDGlobus Medical
$10.69B18.4+23.5%78
IN
INDV stock logo
INDVIndivior
$4.88B20.3+10.3%77
DX
DXCM stock logo
DXCMDexcom
$31.49B32.9+15.5%77
LL
LLY stock logo
LLYEli Lilly and Company
$1.08T41.4+47.4%76

US stock research

About Glaukos Corp. (GKOS) stock

Glaukos Corp. tracked in the US core universe. GKOS was +2.5% in the latest available session at $170.80. Its reported market value was $9.83B with a trailing P/E of 0.0. Latest reported revenue was $612.84M, changing +41.5% year over year, with $-188.05M in net income.

Market snapshot updated Aug 3, 2026, 7:59 PM UTC.

Latest available price
$170.80
Day change
+2.5%
Market cap
$9.83B
P/E (TTM)
0.0
Revenue growth
+41.5%
Industry
Medical Devices
Browse US stocksHealthcare analysisEarnings calendarCompare stocksFundamental analysis guideP/E ratio guideFree cash flow vs net incomeProfit margins explained